These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37578831)

  • 41. Three-year longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder.
    Torres IJ; Qian H; Basivireddy J; Chakrabarty T; Wong H; Lam RW; Yatham LN
    Acta Psychiatr Scand; 2020 Feb; 141(2):98-109. PubMed ID: 31840225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroprogression and Cognitive Functioning in Bipolar Disorder: A Systematic Review.
    Cardoso T; Bauer IE; Meyer TD; Kapczinski F; Soares JC
    Curr Psychiatry Rep; 2015 Sep; 17(9):75. PubMed ID: 26257147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel biomarkers for bipolar disorder.
    Teixeira AL; Barbosa IG; Machado-Vieira R; Rizzo LB; Wieck A; Bauer ME
    Expert Opin Med Diagn; 2013 Mar; 7(2):147-59. PubMed ID: 23530885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progression of the functional deficit in a group of patients with bipolar disorder: a cluster analysis based on longitudinal data.
    López-Villarreal A; Sánchez-Morla EM; Jiménez-López E; Martínez-Vizcaíno V; Aparicio AI; Mateo-Sotos J; Rodriguez-Jimenez R; Vieta E; Santos JL
    Eur Arch Psychiatry Clin Neurosci; 2020 Dec; 270(8):947-957. PubMed ID: 31422453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain gyrification in bipolar disorder: a systematic review of neuroimaging studies.
    Miola A; Cattarinussi G; Loré ML; Ghiotto N; Collantoni E; Sambataro F
    Brain Imaging Behav; 2022 Dec; 16(6):2768-2784. PubMed ID: 36042153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hippocampal volume and verbal memory performance in late-stage bipolar disorder.
    Cao B; Passos IC; Mwangi B; Bauer IE; Zunta-Soares GB; Kapczinski F; Soares JC
    J Psychiatr Res; 2016 Feb; 73():102-107. PubMed ID: 26714201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroprogressive effects of lifetime illness duration in older adults with bipolar disorder.
    Gildengers AG; Chung KH; Huang SH; Begley A; Aizenstein HJ; Tsai SY
    Bipolar Disord; 2014 Sep; 16(6):617-23. PubMed ID: 24716786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood-brain barrier imaging as a potential biomarker for bipolar disorder progression.
    Kamintsky L; Cairns KA; Veksler R; Bowen C; Beyea SD; Friedman A; Calkin C
    Neuroimage Clin; 2020; 26():102049. PubMed ID: 31718955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Adverse Effects of Smoking on Health Outcomes in Bipolar Disorder: A Review and Synthesis of Biological Mechanisms.
    Slyepchenko A; Brunoni AR; McIntyre RS; Quevedo J; Carvalho AF
    Curr Mol Med; 2016; 16(2):187-205. PubMed ID: 26812916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders.
    Morris G; Puri BK; Walker AJ; Maes M; Carvalho AF; Bortolasci CC; Walder K; Berk M
    Neurosci Biobehav Rev; 2019 Dec; 107():862-882. PubMed ID: 31545987
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis.
    Munkholm K; Vinberg M; Kessing LV
    Mol Psychiatry; 2016 Feb; 21(2):216-28. PubMed ID: 26194180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two-year course of cognitive function and instrumental activities of daily living in older adults with bipolar disorder: evidence for neuroprogression?
    Gildengers AG; Chisholm D; Butters MA; Anderson SJ; Begley A; Holm M; Rogers JC; Reynolds CF; Mulsant BH
    Psychol Med; 2013 Apr; 43(4):801-11. PubMed ID: 22846332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diet and Bipolar Disorder: A Review of Its Relationship and Potential Therapeutic Mechanisms of Action.
    Lopresti AL; Jacka FN
    J Altern Complement Med; 2015 Dec; 21(12):733-9. PubMed ID: 26348597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polygenic Risk and Progression to Bipolar or Psychotic Disorders Among Individuals Diagnosed With Unipolar Depression in Early Life.
    Musliner KL; Krebs MD; Albiñana C; Vilhjalmsson B; Agerbo E; Zandi PP; Hougaard DM; Nordentoft M; Børglum AD; Werge T; Mortensen PB; Østergaard SD
    Am J Psychiatry; 2020 Oct; 177(10):936-943. PubMed ID: 32660297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.
    Berk M; Kapczinski F; Andreazza AC; Dean OM; Giorlando F; Maes M; Yücel M; Gama CS; Dodd S; Dean B; Magalhães PV; Amminger P; McGorry P; Malhi GS
    Neurosci Biobehav Rev; 2011 Jan; 35(3):804-17. PubMed ID: 20934453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreased right hippocampal volumes and neuroprogression markers in adolescents with bipolar disorder.
    Inal-Emiroglu FN; Resmi H; Karabay N; Guleryuz H; Baykara B; Cevher N; Akay A
    Neuropsychobiology; 2015; 71(3):140-8. PubMed ID: 25925781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal Structural Brain Changes in Bipolar Disorder: A Multicenter Neuroimaging Study of 1232 Individuals by the ENIGMA Bipolar Disorder Working Group.
    Abé C; Ching CRK; Liberg B; Lebedev AV; Agartz I; Akudjedu TN; Alda M; Alnæs D; Alonso-Lana S; Benedetti F; Berk M; Bøen E; Bonnin CDM; Breuer F; Brosch K; Brouwer RM; Canales-Rodríguez EJ; Cannon DM; Chye Y; Dahl A; Dandash O; Dannlowski U; Dohm K; Elvsåshagen T; Fisch L; Fullerton JM; Goikolea JM; Grotegerd D; Haatveit B; Hahn T; Hajek T; Heindel W; Ingvar M; Sim K; Kircher TTJ; Lenroot RK; Malt UF; McDonald C; McWhinney SR; Melle I; Meller T; Melloni EMT; Mitchell PB; Nabulsi L; Nenadić I; Opel N; Overs BJ; Panicalli F; Pfarr JK; Poletti S; Pomarol-Clotet E; Radua J; Repple J; Ringwald KG; Roberts G; Rodriguez-Cano E; Salvador R; Sarink K; Sarró S; Schmitt S; Stein F; Suo C; Thomopoulos SI; Tronchin G; Vieta E; Westlye LT; White AG; Yatham LN; Zak N; Thompson PM; Andreassen OA; Landén M;
    Biol Psychiatry; 2022 Mar; 91(6):582-592. PubMed ID: 34809987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bipolar disorder and dementia: where is the link?
    Masouy A; Chopard G; Vandel P; Magnin E; Rumbach L; Sechter D; Haffen E
    Psychogeriatrics; 2011 Mar; 11(1):60-7. PubMed ID: 21447111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuroinflammation and neuroprogression produced by oxidative stress in euthymic bipolar patients with different onset disease times.
    Lima DD; Cyrino LAR; Ferreira GK; Magro DDD; Calegari CR; Cabral H; Cavichioli N; Ramos SA; Ullmann OM; Mayer Y; Pscheidt LC; Schramm MA; Tomasi MC; Stammerjohann FLS; Delmonego L; Packer MH; Fiamoncini H
    Sci Rep; 2022 Oct; 12(1):16742. PubMed ID: 36202963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotensin receptor blockers for bipolar disorder.
    de Góis Queiroz AI; Medeiros CD; Ribeiro BM; de Lucena DF; Macêdo DS
    Med Hypotheses; 2013 Mar; 80(3):259-63. PubMed ID: 23265360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.